Copanlisib*
Clinical Trials

Learn about ongoing studies
investigating patients with relapsed/refractory indolent
non-Hodgkin's lymphoma (iNHL).
*Copanlisib is being investigated for uses that are not approved by the FDA, the EMA, or other health authorities.